NL-OMON45536已完成不适用
InTerlaboratory Evaluation of a GastroIntestinal Activity ErgoMeterTest in Non-intense Trained PersOns - TEMPO! 2.0
Hogeschool Utrecht0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •-Generally healthy
- •-Recreational athlete with at least two years of cycling experience of at least twice a week
- •-18-35 years old
- •-Meeting criteria of valid max-test
- •-Body mass index (BMI) 18.5-25 kg/m2
- •-Veins suitable for blood sampling at inspection
排除标准
- •-Diagnosed with an immune disease such as diabetes, coeliac disease, rheumatoid arthritis
- •-Diagnosed with an gastro-intestinal disease such as Crohn*s disease, colitis ulcerosa,
- •irritable bowel syndrome
- •-abnormal ECG, e.g. an aberrant QT time
- •-Allergies
- •-Use of hard drugs
- •-Use of pre- and probiotics
- •-(Chronic) use of specific medicines:
- •*chronic use of NSAIDs: aspirin, ibuprofen, corticosteroids
- •*chronic use of antidepressiva, antacids (Rennie), benzodiazepines (Valium)
- •* drugs against abdominal pain and cramping (e.g.buscopan, imodium),
- •-Participation in other scientific studies within 1 month before the preliminary testing
- •-Blood donation six weeks prior to the start of the study
研究者
相似试验
撤回
不适用
InTerlaboratory Evaluation of a GastroIntestinal Activity Ergometertest in Non-intense Trained PersOnsgastrointestinal activityintestinal barrier function10017969NL-OMON43135Hogeschool Utrecht16
尚未招募
不适用
A clinical trial to evaluate to GastroIntestinal protective eFfect of Tegoprazan for utilization of potent P2Y12 inhibitors in patients with Acute Coronary Syndrome (GIFT-ACS trial)Diseases of the circulatory systemKCT0007897Yonsei University Yongin Severance Hospital124
招募中
3 期
Extracorporeal magnetic navigation system of capsule endoscopyGastrointestinal Malignant Tumor, Gastric or Duodenal Ulcer, Gastrointestinal Bleeding,Gastrointestinal Benign Tumor, Inflammatory Bowel Disease, Gastrointestinal screeningJPRN-jRCT1092220114Hidetoshi Ohta40
招募中
不适用
The study of assessment for gastrointestinal motility function using radiopaque markercolorectal cancerJPRN-UMIN000005297ippon Medical School Department of surgery100
进行中（未招募）
1 期
A new way of evaluating the adverse effects of opioids on the gut.Opioid-induced bowel dysfunction.MedDRA version: 18.0Level: LLTClassification code 10071128Term: Opioid induced constipationSystem Organ Class: 100000004856EUCTR2013-001540-60-DKMech-Sense, Aalborg University Hospital